Cargando…

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease

Alterations in lipid composition and disturbed lipoprotein metabolism are involved in the pathomechanism of Huntington’s disease (HD). Here, we measured 112 lipoprotein subfractions and components in the plasma of 20 normal controls, 24 symptomatic (sympHD) and 9 presymptomatic (preHD) HD patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Kuo-Hsuan, Cheng, Mei-Ling, Lo, Chi-Jen, Fan, Chun-Ming, Wu, Yih-Ru, Chen, Chiung-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913722/ https://www.ncbi.nlm.nih.gov/pubmed/36766727 http://dx.doi.org/10.3390/cells12030385

Ejemplares similares

Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s disease patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2017)

Altered Aconitase 2 Activity in Huntington’s Disease Peripheral Blood Cells and Mouse Model Striatum
por: Chen, Chiung-Mei, et al.
Publicado: (2017)

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2012)

Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease
por: Huang, Yen-Chu, et al.
Publicado: (2011)

High Protein Diet and Huntington's Disease
por: Chen, Chiung-Mei, et al.
Publicado: (2015)

Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
por: Lo, Chi-Jen, et al.
Publicado: (2023)

Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022)

STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015)

Fixel-Based Analysis Effectively Identifies White Matter Tract Degeneration in Huntington’s Disease
por: Oh, Sher Li, et al.
Publicado: (2021)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome
por: Tang, Hsiang-Yu, et al.
Publicado: (2017)

Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease
por: Siew, Jian Jing, et al.
Publicado: (2019)

Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement
por: Chiu, Ya-Jen, et al.
Publicado: (2021)

Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022)

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
por: Chen, Chiung-Mei, et al.
Publicado: (2021)

Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
por: Wu, Hsiu-Chuan, et al.
Publicado: (2021)

Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation
por: Chen, I-Cheng, et al.
Publicado: (2018)

Myasthenia gravis and independent risk factors for recurrent infection: a retrospective cohort study
por: Chien, Chia-Yin, et al.
Publicado: (2023)

Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
por: Wei, Pei-Cih, et al.
Publicado: (2019)

New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models
por: Chen, Chiung-Mei, et al.
Publicado: (2020)

Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan
por: Chen, Yi-Chun, et al.
Publicado: (2016)

Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients
por: Liao, Ming-Feng, et al.
Publicado: (2014)

Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2023)

Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation
por: Chiu, Ya-Jen, et al.
Publicado: (2020)

Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers
por: Lin, Chia-Ni, et al.
Publicado: (2021)

4472 Plasma Neurofilament Light as a Biomarker for Pediatric Patients with Huntington’s Disease
por: Schultz, Jordan L
Publicado: (2020)

Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage
por: Chen, Yi-Chun, et al.
Publicado: (2018)

Aqueous Extract of Paeonia lactiflora and Paeoniflorin as Aggregation Reducers Targeting Chaperones in Cell Models of Spinocerebellar Ataxia 3
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models
por: Chen, Chiung-Mei, et al.
Publicado: (2019)

Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers
por: Skene, Debra J., et al.
Publicado: (2017)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci
por: Chen, I-Cheng, et al.
Publicado: (2009)

Internal Ribosome Entry Segment Activity of ATXN8 Opposite Strand RNA
por: Chen, I-Cheng, et al.
Publicado: (2013)

Clinical Correlations of Motor and Somatosensory Evoked Potentials in Neuromyelitis Optica
por: Tsao, Wei-Chia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0n7t08cu7jd3u55du4p9c4i1cl